Effects of genetic deletion of endogenous opioid system components on the reinstatement of cocaine-seeking behavior in mice

Neuropsychopharmacology

Volumn 39, Issue 13, 2014, Pages 2974-2988

  Gutiérrez Cuesta, Javier ^a   Burokas, Aurelijus ^a,b   Mancino, Samantha ^a   Kummer, Sami ^a   Martín García, Elena ^a   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DELTA OPIATE RECEPTOR; ENDORPHIN; ENKEPHALIN; MU OPIATE RECEPTOR; PRODYNORPHIN; PROENKEPHALIN; LOCAL ANESTHETIC AGENT; PREPROENKEPHALIN; PROTEIN C FOS; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; GENE DELETION; GENOTYPE; MEMORY; MOUSE; NONHUMAN; RELAPSE; REWARD; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; ASSOCIATION; DEFICIENCY; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REINFORCEMENT;

ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; COCAINE; CONDITIONING, OPERANT; CUES; DRUG-SEEKING BEHAVIOR; ENKEPHALINS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 84936142874     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.149     Document Type: Article

References (49)

1. Abdoullaye D, Acevedo I, Adebayo AA, Behrmann-Godel J, Benjamin RC, Bock DG et al (2010). Permanent Genetic Resources added to Molecular Ecology Resources Database 1 August 2009-30 September 2009. Mol Ecol Res 10: 232-236.
2. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th edition DSM-5) and proposed draft revisions (DSM-V). American Psychiatric Press: Washington, DC.
3. Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005). Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology 183: 118-126.
4. Becker A, Grecksch G, Kraus J, Loh HH, Schroeder H, Hollt V (2002). Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 365: 296-302.
5. Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A et al (2005). Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 25: 1103-1112.
6. Berrendero F, Plaza-Zabala A, Galeote L, Flores A, Bura SA, Kieffer BL et al (2012). Influence of delta-opioid receptors in the behavioral effects of nicotine. Neuropsychopharmacology 37: 2332-2344.
7. Blasio A, Steardo L, Sabino V, Cottone P (2013). Opioid system in the medial prefrontal cortex mediates binge-like eating. Addict Biol; doi:10.1111/adb.12033 (e-pub ahead of print).
8. Bodnar RJ (2004). Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25: 697-725.
9. Bodnar RJ (2008). Endogenous opiates and behavior: 2007. Peptides 29: 2292-2375.
10. Burattini C, Burbassi S, Aicardi G, Cervo L (2008). Effects of naltrexone on cocaine- and sucrose-seeking behavior in response to associated stimuli in rats. Int J Neuropsychopharmacol 11: 103-109.
11. Butelman ER, Yuferov V, Kreek MJ (2012). Kappa-opioid receptor/ dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci 35: 587-596.
12. Charbogne P, Kieffer BL, Befort K (2014). 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 76: 204-217.
13. Comer SD, Lac ST, Curtis LK, Carroll ME (1993). Effects of buprenorphine and naltrexone on reinstatement of cocainereinforced responding in rats. J Pharmacol Exp Ther 267: 1470-1477.
14. Crespo JA, Manzanares J, Oliva JM, Corchero J, Palomo T, Ambrosio E (2001). Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology 25: 185-194.
15. Dela Cruz JA, Bae VS, Icaza-Cukali D, Sampson C, Bamshad D, Samra A et al (2012). Critical role of NMDA but not opioid receptors in the acquisition of fat-conditioned flavor preferences in rats. Neurobiol Learn Mem 98: 341-347.
16. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F et al (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
17. Galeote L, Berrendero F, Bura SA, Zimmer A, Maldonado R (2009). Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. Int J Neuropsychopharmacol 12: 615-625.
18. Gerrits MA, Kuzmin AV, van Ree JM (2005). Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. Eur Neuropsychopharmacol 15: 297-303.
19. Jamot L, Matthes HW, Simonin F, Kieffer BL, Roder JC (2003). Differential involvement of the mu and kappa opioid receptors in spatial learning. Genes Brain Behav 2: 80-92.
20. Kelley AE (2004). Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44: 161-179.
21. Kieffer BL, Gaveriaux-Ruff C (2002). Exploring the opioid system by gene knockout. Prog Neurobiol 66: 285-306.
22. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ et al (1996). Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383: 535-538.
23. Law PY, Wong YH, Loh HH (2000). Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389-430.
24. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009). Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
25. Le Merrer J, Plaza-Zabala A, Del Boca C, Matifas A, Maldonado R, Kieffer BL (2011). Deletion of the delta opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry 69: 700-703.
26. Lutter M, Nestler EJ (2009). Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr 139: 629-632.
27. Lutz PE, Kieffer BL (2013). The multiple facets of opioid receptor function: implications for addiction. Curr Opin Neurobiol 23: 473-479.
28. Marinelli PW, Bai L, Quirion R, Gianoulakis C (2005). A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res 29: 1821-1828.
29. Martin-Garcia E, Burokas A, Kostrzewa E, Gieryk A, Korostynski M, Ziolkowska B et al (2011). New operant model of reinstatement of food-seeking behavior in mice. Psychopharmacology 215: 49-70.
30. Mathon DS, Lesscher HM, Gerrits MA, Kamal A, Pintar JE, Schuller AG et al (2005). Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice. Neuroscience 130: 359-367.
31. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823.
32. McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C (2006). Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31: 787-794.
33. Miller NS, Gold MS (1994). Dissociation of 'conscious desire' (craving) from and relapse in alcohol and cocaine dependence. Ann Clin Psychiatry 6: 99-106.
34. Schroeder JA, Hummel M, Simpson AD, Sheikh R, Soderman AR, Unterwald EM (2007). A role for mu opioid receptors in cocaineinduced activity, sensitization, and reward in the rat. Psychopharmacology 195: 265-272.
35. Shippenberg TS, Zapata A, Chefer VI (2007). Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116: 306-321.
36. Shoblock JR, Maidment NT (2007). Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal. Neuroscience 149: 642-649.
37. Simmons D, Self DW (2009). Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Neuropsychopharmacology 34: 1946-1957.
38. Soderman AR, Unterwald EM (2008). Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation. Neuroscience 154: 1506-1516.
39. Soria G, Barbano MF, Maldonado R, Valverde O (2008). A reliable method to study cue-, priming-, and stress-induced reinstatement of cocaine self-administration in mice. Psychopharmacology 199: 593-603.
40. Soria G, Mendizabal V, Tourino C, Robledo P, Ledent C, Parmentier M et al (2005). Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30: 1670-1680.
41. Taha SA (2010). Preference or fat? Revisiting opioid effects on food intake. Physiol Behav 100: 429-437.
42. Tang XC, McFarland K, Cagle S, Kalivas PW (2005). Cocaineinduced reinstatement requires endogenous stimulation of muopioid receptors in the ventral pallidum. J Neurosci 25: 4512-4520.
43. Trifilieff P, Martinez D (2013). Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence. Front Psychiatry 4: 44.
44. Trigo JM, Martin-Garcia E, Berrendero F, Robledo P, Maldonado R (2010). The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend 108: 183-194.
45. Trigo JM, Zimmer A, Maldonado R (2009). Nicotine anxiogenic and rewarding effects are decreased in mice lacking betaendorphin. Neuropharmacology 56: 1147-1153.
46. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 Suppl 1: 3-8.
47. Ward SJ, Martin TJ, Roberts DC (2003). Beta-funaltrexamine affects cocaine self-administration in rats responding on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 75: 301-307.
48. Weiss F (2010). Advances in animal models of relapse for addiction research. In: Kuhn CM and Koob GF (eds). Advances in the Neuroscience of Addiction. 2nd edn, Boca Raton (FL): London.
49. Zhang M, Gosnell BA, Kelley AE (1998). Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 285: 908-914.